Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes

摘要

BackgroundBuilding on an approach applied to cardiovascular and cancer research, we estimated the economic returns from United Kingdom public- and charitable-funded musculoskeletal disease (MSD) research that arise from the net value of the improved health outcomes in the United Kingdom.